TY - JOUR
T1 - Gold and Carbon-Based Nano-theranostics
T2 - An Overview on the Developments and Applications for Cancer Phototherapy
AU - Shailendrakumar, Ashay Manisha
AU - Tippavajhala, Vamshi Krishna
N1 - Publisher Copyright:
© 2022 The Author (s).
PY - 2022
Y1 - 2022
N2 - Nano-theranostics (NTs) are versatile nanomaterials, explored in the current scenario of cancer therapy. A nano-theranostic material alone can diagnose and generate a therapeutic effect. Various materials have been explored for their NT action like gold and carbon-based material. The photon-based cancer theranostics has grabbed the attention of researchers due to their localized and trigger activated effect. NTs have shown a promising result in pre-clinical and clinical studies. The current review illustrates the meticulous efforts conducted by researchers across the globe to innovate and explore the photon-based cancer NT platforms of gold and carbon with their application in cancer therapy.
AB - Nano-theranostics (NTs) are versatile nanomaterials, explored in the current scenario of cancer therapy. A nano-theranostic material alone can diagnose and generate a therapeutic effect. Various materials have been explored for their NT action like gold and carbon-based material. The photon-based cancer theranostics has grabbed the attention of researchers due to their localized and trigger activated effect. NTs have shown a promising result in pre-clinical and clinical studies. The current review illustrates the meticulous efforts conducted by researchers across the globe to innovate and explore the photon-based cancer NT platforms of gold and carbon with their application in cancer therapy.
UR - http://www.scopus.com/inward/record.url?scp=85140416408&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140416408&partnerID=8YFLogxK
U2 - 10.34172/apb.2022.071
DO - 10.34172/apb.2022.071
M3 - Review article
AN - SCOPUS:85140416408
SN - 2228-5881
VL - 12
SP - 673
EP - 685
JO - Advanced Pharmaceutical Bulletin
JF - Advanced Pharmaceutical Bulletin
IS - 4
ER -